Bills · HR 2553
IN COMMITTEE· 119TH CONGRESS
House BillHR 2553Health care costs and insurancePrescription drugs
Capping Prescription Costs Act of 2025
INTRO APR 1· LAST ACTION APR 1
READING
4MIN
COSPONSORS
9
READER REACTIONS0 TOTAL
NO VOTES YET · BE THE FIRST
- Introduced only
LEGISLATIVE PROGRESS
STEP 2 / 8Introduced
In Committee
Reported
Passed House
Passed Senate
Conference
To President
Became Law
WHAT THE BILL DOES
AI-writtenThis bill matters because prescription drug costs are a major financial burden for many American families, sometimes leading people to skip necessary medications or go into debt. By setting a clear annual limit on what individuals and families have to pay for their drugs, the bill aims to provide financial relief and stability, making healthcare more accessible and predictable.
If this bill becomes law, it could prevent situations where people face thousands of dollars in annual drug costs, improving health outcomes by ensuring more people can afford their prescriptions. If it doesn't pass, many Americans will continue to face potentially unlimited or very high out-of-pocket costs for their medications, leaving them vulnerable to financial hardship when managing chronic diseases or sudden health issues.
KEY PROVISIONS
3AI-extractedPROVISION 01
Establishes a maximum annual out-of-pocket cost for prescription drugs at $2,000 for individuals and $4,000 for families, beginning in 2026.
This directly limits the financial burden on individuals and families who depend on expensive medications.
PROVISION 02
Applies these prescription drug cost-sharing caps to Qualified Health Plans (those on the ACA marketplace) and Group Health Plans (employer-sponsored plans).
The cap extends broadly across most health insurance types, ensuring wide protection for insured Americans.
PROVISION 03
Mandates that the annual caps will be adjusted each year after 2026 based on the medical care component of the consumer price index.
This provision helps ensure the cap remains relevant and provides consistent financial protection against rising drug costs over time.
SPONSORSHIP
1 + 9
D· Nevada
YRS IN OFFICE
13
BILLS LED
33
COSPONSOR BREAKDOWNBIPARTISAN · 0%
DEM 9 REP 0 IND 0
ACTION TIMELINE
2 EVENTSAPR 1
Introduced in House
APR 1
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Education and Workforce, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
BILL INFO
TypeHouse Bill
NumberHR 2553
Congress119th
StatusIn Committee
IntroducedApr 1, 2025
Last actionApr 1, 2025
READER REACTIONS
OVERALL SENTIMENT
No reactions yet. Be the first to weigh in.
Discussion
Loading comments...
IN COMMITTEE· 119TH CONGRESS · WAYS AND MEANS COMMITTEE · INTRODUCED APR 1, 2025
House BillHR 2553Health care costs and insurancePrescription drugs
Capping Prescription Costs Act of 2025
INTRODUCED APR 1, 2025· LAST ACTION APR 1, 2025
PASSAGE CHANCES
—%
READING
4 min
COSPONSORS
9
COMPLEXITY
Moderate
